DK1216043T3 - Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater) - Google Patents

Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)

Info

Publication number
DK1216043T3
DK1216043T3 DK00969359T DK00969359T DK1216043T3 DK 1216043 T3 DK1216043 T3 DK 1216043T3 DK 00969359 T DK00969359 T DK 00969359T DK 00969359 T DK00969359 T DK 00969359T DK 1216043 T3 DK1216043 T3 DK 1216043T3
Authority
DK
Denmark
Prior art keywords
derivatives
lipoic acid
delayed
alpha
containing alpha
Prior art date
Application number
DK00969359T
Other languages
Danish (da)
English (en)
Inventor
Hans Schuhbauer
Ivo Pischel
Andreas Bernkop-Schnuerch
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10045904A external-priority patent/DE10045904B4/de
Application filed by Degussa filed Critical Degussa
Application granted granted Critical
Publication of DK1216043T3 publication Critical patent/DK1216043T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • General Preparation And Processing Of Foods (AREA)
DK00969359T 1999-10-01 2000-09-29 Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater) DK1216043T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19947330 1999-10-01
DE10045904A DE10045904B4 (de) 1999-10-01 2000-09-16 alpha-Liponsäure(-Derivate) enthaltende Retardform
PCT/EP2000/009585 WO2001024795A1 (fr) 1999-10-01 2000-09-29 Formulation a effet retard contenant de l'acide alpha-lipoique ou des derives de celui-ci

Publications (1)

Publication Number Publication Date
DK1216043T3 true DK1216043T3 (da) 2003-09-01

Family

ID=26007080

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00969359T DK1216043T3 (da) 1999-10-01 2000-09-29 Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)

Country Status (10)

Country Link
EP (1) EP1216043B1 (fr)
JP (1) JP2003510358A (fr)
CN (1) CN1232252C (fr)
AT (1) ATE239469T1 (fr)
AU (1) AU7911000A (fr)
CA (1) CA2385867C (fr)
DK (1) DK1216043T3 (fr)
ES (1) ES2193111T3 (fr)
PT (1) PT1216043E (fr)
WO (1) WO2001024795A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030180337A1 (en) * 2000-06-06 2003-09-25 Harald Streicher Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
KR101100803B1 (ko) * 2009-04-24 2011-12-29 서울과학기술대학교 산학협력단 리포아마이드가 결합된 고분자화합물과 이의 제조방법
CN101665569B (zh) * 2009-07-23 2011-09-28 苏州大学 侧链用硫辛酸修饰的亲水性聚合物及其制备和应用
CN102212146B (zh) * 2009-07-23 2013-02-13 苏州大学 一种侧链用硫辛酸修饰的亲水性聚合物
CN107789350A (zh) * 2016-08-31 2018-03-13 杜建 包含硫辛酸及/或其衍生物的组合物及其应用
CN110387142B (zh) * 2019-08-14 2021-08-17 桂林理工大学 一种负载有脂溶性色素的桃胶多糖纳米球的制备方法
CN114656616A (zh) * 2022-03-31 2022-06-24 深圳先进技术研究院 一种基于硫辛酸或/和其衍生物的本征型自修复的导热高分子聚合物及其制备方法和应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61293931A (ja) * 1985-06-24 1986-12-24 Teijin Ltd 徐放性医薬品組成物
JPS63101332A (ja) * 1986-10-17 1988-05-06 Sato Seiyaku Kk 経口投与用徐放性製剤
SE508601C2 (sv) * 1989-11-09 1998-10-19 Asta Medica Ag Läkemedel, vilka som aktiv substans innehåller karboxylsyror innehållande svavel samt deras användning för bekämpning av retrovirus
JPH0418036A (ja) * 1990-05-09 1992-01-22 Kurita Water Ind Ltd 薬剤組成物
IT1243390B (it) * 1990-11-22 1994-06-10 Vectorpharma Int Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
ES2111659T3 (es) * 1992-03-11 1998-03-16 Asta Medica Ag Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion.
JPH06293801A (ja) * 1993-04-07 1994-10-21 Nippon Suisan Kaisha Ltd アルカリ域でも水溶解性を示すキトサン及びその製造方法
GB9416884D0 (en) * 1994-08-20 1994-10-12 Danbiosyst Uk Drug delivery compositions
DE4433764A1 (de) * 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit

Also Published As

Publication number Publication date
PT1216043E (pt) 2003-09-30
CN1377267A (zh) 2002-10-30
CA2385867A1 (fr) 2001-04-12
EP1216043A1 (fr) 2002-06-26
AU7911000A (en) 2001-05-10
EP1216043B1 (fr) 2003-05-07
WO2001024795A1 (fr) 2001-04-12
CA2385867C (fr) 2009-09-01
JP2003510358A (ja) 2003-03-18
CN1232252C (zh) 2005-12-21
ATE239469T1 (de) 2003-05-15
ES2193111T3 (es) 2003-11-01

Similar Documents

Publication Publication Date Title
TW376319B (en) Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine
PT1196414E (pt) Pro-farmacos de inibidores carbamato de impdh
AU3357800A (en) Method of preparing alkylated salicylamides
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
RS50360B (sr) Farmaceutske formulacije derivata platine
NO962040L (no) Mikroinnkapslede 3-piperidinyl-substituerte 1,2-benzisoksazoler og 1,2-benzisotiazoler
PT1401501E (pt) Composicoes farmaceuticas orais com libertacao modificada do ingrediente activo
WO2001095856A3 (fr) Derive d'uree en tant qu'agent anticancereux et son procede de preparation
HU9502843D0 (en) Pharmaceutical composition
TWI256292B (en) Reduction inhibitory agent for active oxygen eliminating activity
DE60017361D1 (de) Direktverpressbare matrix zur kontrollierten abgabe von einmaltäglichen dosen von clarithromycin
DK1216043T3 (da) Formulering med forsinket frigivelse indeholdende alfa-liponsyre-(derivater)
NO20062857L (no) Farmasoytisk preparat omfattende et sink-hyaluronatkompleks for behandling av multippel sklerose
MXPA02006051A (es) Compuestos de amonio cuaternario ciclico.
TWI266775B (en) Polyacrylic acid hydrazide and crosslinking or hardening agent for resin
DK0744947T3 (da) Metronidazolpræparater med modificeret afgivelse og fremgangsmåde til deres fremstilling og anvendelse
IL131216A0 (en) Drugs inhibiting progress of pterygium and postoperative recurrence of the same
TW200500093A (en) A platform for transdermal formulations (PTF)
MY126962A (en) A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
MXPA05008711A (es) Uso de r-10-hidroxi-10,11-dihidro-carbamazepina en dolor neuropatico.
DE69927997D1 (de) Neuartige pyrimidin-derivate und verfahren zu ihrer herstellung
WO1996028151A3 (fr) Utilisation d'un activateur de la pyruvate dehydrogenase pour le traitement de l'ischemie dans les membres
NO20022000L (no) 6-metoksy-2-naftyleddiksyre-prodrogesammensetninger til behandling av inflammasjon
TW200505872A (en) Hepatitis C virus inhibitors
DE60014915D1 (de) Hypoxanthin- und thiohypxanthin-verbindungen